Table of Contents Chapter 1 Overview of Biotechnology 1.1 Definition of Biotechnology in This Report 1.2 Commercial Types of Biotechnology 1.2.1 DNA Sequencing 1.2.2 Nanobiotechnology 1.2.3 Tissue engineering and Regeneration 1.2.4 Fermentation 1.2.5 Cell Based Assay 1.2.6 PCR Technology 1.2.7 Chromatography Market 1.2.8 Others 1.3 Downstream Application of Biotechnology 1.3.1 Health 1.3.2 Food & Agriculture 1.3.3 Natural Resources & Environment 1.3.4 Industrial Processing 1.3.5 Bioinformatics 1.3.6 Others 1.4 Development History of Biotechnology 1.5 Market Status and Trend of Biotechnology 2013-2023 1.5.1 Europe Biotechnology Market Status and Trend 2013-2023 1.5.2 Regional Biotechnology Market Status and Trend 2013-2023 Chapter 2 Europe Market Status and Forecast by Regions 2.1 Market Status of Biotechnology in Europe 2013-2017 2.2 Consumption Market of Biotechnology in Europe by Regions 2.2.1 Consumption Volume of Biotechnology in Europe by Regions 2.2.2 Revenue of Biotechnology in Europe by Regions 2.3 Market Analysis of Biotechnology in Europe by Regions 2.3.1 Market Analysis of Biotechnology in Germany 2013-2017 2.3.2 Market Analysis of Biotechnology in United Kingdom 2013-2017 2.3.3 Market Analysis of Biotechnology in France 2013-2017 2.3.4 Market Analysis of Biotechnology in Italy 2013-2017 2.3.5 Market Analysis of Biotechnology in Spain 2013-2017 2.3.6 Market Analysis of Biotechnology in Benelux 2013-2017 2.3.7 Market Analysis of Biotechnology in Russia 2013-2017 2.4 Market Development Forecast of Biotechnology in Europe 2018-2023 2.4.1 Market Development Forecast of Biotechnology in Europe 2018-2023 2.4.2 Market Development Forecast of Biotechnology by Regions 2018-2023 Chapter 3 Europe Market Status and Forecast by Types 3.1 Whole Europe Market Status by Types 3.1.1 Consumption Volume of Biotechnology in Europe by Types 3.1.2 Revenue of Biotechnology in Europe by Types 3.2 Europe Market Status by Types in Major Countries 3.2.1 Market Status by Types in Germany 3.2.2 Market Status by Types in United Kingdom 3.2.3 Market Status by Types in France 3.2.4 Market Status by Types in Italy 3.2.5 Market Status by Types in Spain 3.2.6 Market Status by Types in Benelux 3.2.7 Market Status by Types in Russia 3.3 Market Forecast of Biotechnology in Europe by Types Chapter 4 Europe Market Status and Forecast by Downstream Industry 4.1 Demand Volume of Biotechnology in Europe by Downstream Industry 4.2 Demand Volume of Biotechnology by Downstream Industry in Major Countries 4.2.1 Demand Volume of Biotechnology by Downstream Industry in Germany 4.2.2 Demand Volume of Biotechnology by Downstream Industry in United Kingdom 4.2.3 Demand Volume of Biotechnology by Downstream Industry in France 4.2.4 Demand Volume of Biotechnology by Downstream Industry in Italy 4.2.5 Demand Volume of Biotechnology by Downstream Industry in Spain 4.2.6 Demand Volume of Biotechnology by Downstream Industry in Benelux 4.2.7 Demand Volume of Biotechnology by Downstream Industry in Russia 4.3 Market Forecast of Biotechnology in Europe by Downstream Industry Chapter 5 Market Driving Factor Analysis of Biotechnology 5.1 Europe Economy Situation and Trend Overview 5.2 Biotechnology Downstream Industry Situation and Trend Overview Chapter 6 Biotechnology Market Competition Status by Major Players in Europe 6.1 Sales Volume of Biotechnology in Europe by Major Players 6.2 Revenue of Biotechnology in Europe by Major Players 6.3 Basic Information of Biotechnology by Major Players 6.3.1 Headquarters Location and Established Time of Biotechnology Major Players 6.3.2 Employees and Revenue Level of Biotechnology Major Players 6.4 Market Competition News and Trend 6.4.1 Merger, Consolidation or Acquisition News 6.4.2 Investment or Disinvestment News 6.4.3 New Product Development and Launch Chapter 7 Biotechnology Major Manufacturers Introduction and Market Data 7.1 Johnson & Johnson Services, Inc. 7.1.1 Company profile 7.1.2 Representative Biotechnology Product 7.1.3 Biotechnology Sales, Revenue, Price and Gross Margin of Johnson & Johnson Services, Inc. 7.2 F. Hoffmann-La Roche Ltd 7.2.1 Company profile 7.2.2 Representative Biotechnology Product 7.2.3 Biotechnology Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche Ltd 7.3 Pfizer 7.3.1 Company profile 7.3.2 Representative Biotechnology Product 7.3.3 Biotechnology Sales, Revenue, Price and Gross Margin of Pfizer 7.4 Merck & Co. 7.4.1 Company profile 7.4.2 Representative Biotechnology Product 7.4.3 Biotechnology Sales, Revenue, Price and Gross Margin of Merck & Co. 7.5 Sanofi 7.5.1 Company profile 7.5.2 Representative Biotechnology Product 7.5.3 Biotechnology Sales, Revenue, Price and Gross Margin of Sanofi 7.6 AstraZeneca 7.6.1 Company profile 7.6.2 Representative Biotechnology Product 7.6.3 Biotechnology Sales, Revenue, Price and Gross Margin of AstraZeneca 7.7 Gilead 7.7.1 Company profile 7.7.2 Representative Biotechnology Product 7.7.3 Biotechnology Sales, Revenue, Price and Gross Margin of Gilead 7.8 CELGENE CORPORATION 7.8.1 Company profile 7.8.2 Representative Biotechnology Product 7.8.3 Biotechnology Sales, Revenue, Price and Gross Margin of CELGENE CORPORATION 7.9 Biogen 7.9.1 Company profile 7.9.2 Representative Biotechnology Product 7.9.3 Biotechnology Sales, Revenue, Price and Gross Margin of Biogen 7.10 Amgen, Inc 7.10.1 Company profile 7.10.2 Representative Biotechnology Product 7.10.3 Biotechnology Sales, Revenue, Price and Gross Margin of Amgen, Inc 7.11 Abbott 7.11.1 Company profile 7.11.2 Representative Biotechnology Product 7.11.3 Biotechnology Sales, Revenue, Price and Gross Margin of Abbott 7.12 Novo Nordisk A/S 7.12.1 Company profile 7.12.2 Representative Biotechnology Product 7.12.3 Biotechnology Sales, Revenue, Price and Gross Margin of Novo Nordisk A/S 7.13 Novartis AG 7.13.1 Company profile 7.13.2 Representative Biotechnology Product 7.13.3 Biotechnology Sales, Revenue, Price and Gross Margin of Novartis AG 7.14 Lonza 7.14.1 Company profile 7.14.2 Representative Biotechnology Product 7.14.3 Biotechnology Sales, Revenue, Price and Gross Margin of Lonza Chapter 8 Upstream and Downstream Market Analysis of Biotechnology 8.1 Industry Chain of Biotechnology 8.2 Upstream Market and Representative Companies Analysis 8.3 Downstream Market and Representative Companies Analysis Chapter 9 Cost and Gross Margin Analysis of Biotechnology 9.1 Cost Structure Analysis of Biotechnology 9.2 Raw Materials Cost Analysis of Biotechnology 9.3 Labor Cost Analysis of Biotechnology 9.4 Manufacturing Expenses Analysis of Biotechnology Chapter 10 Marketing Status Analysis of Biotechnology 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List Chapter 11 Report Conclusion Chapter 12 Research Methodology and Reference 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Reference

List of Tables Table Advantage and Disadvantage of DNA Sequencing Table Advantage and Disadvantage of Nanobiotechnology Table Advantage and Disadvantage of Tissue engineering and Regeneration Table Advantage and Disadvantage of Fermentation Table Advantage and Disadvantage of Cell Based Assay Table Advantage and Disadvantage of PCR Technology Table Advantage and Disadvantage of Chromatography Market Table Advantage and Disadvantage of Others Table Consumption Volume of Biotechnology in Europe by Regions 2013-2017 Table Revenue of Biotechnology in Europe by Regions 2013-2017 Table Consumption Volume of Biotechnology in Europe by Regions 2018-2023 Table Revenue of Biotechnology in Europe by Regions 2018-2023 Table Consumption Volume of Biotechnology in Europe by Types 2013-2017 Table Revenue of Biotechnology in Europe by Types 2013-2017 Table Consumption Volume of Biotechnology by Types in Germany 2013-2017 Table Consumption Volume of Biotechnology by Types in United Kingdom 2013-2017 Table Consumption Volume of Biotechnology by Types in France 2013-2017 Table Consumption Volume of Biotechnology by Types in Italy 2013-2017 Table Consumption Volume of Biotechnology by Types in Spain 2013-2017 Table Consumption Volume of Biotechnology by Types in Benelux 2013-2017 Table Consumption Volume of Biotechnology by Types in Russia 2013-2017 Table Consumption Volume Forecast of Biotechnology in Europe by Types 2018-2023 Table Revenue Forecast of Biotechnology in Europe by Types 2018-2023 Table Demand Volume of Biotechnology in Europe by Downstream Industry 2013-2017 Table Demand Volume of Biotechnology by Downstream Industry in Germany 2013-2017 Table Demand Volume of Biotechnology by Downstream Industry in United Kingdom 2013-2017 Table Demand Volume of Biotechnology by Downstream Industry in France 2013-2017 Table Demand Volume of Biotechnology by Downstream Industry in Italy 2013-2017 Table Demand Volume of Biotechnology by Downstream Industry in Spain 2013-2017 Table Demand Volume of Biotechnology by Downstream Industry in Benelux 2013-2017 Table Demand Volume of Biotechnology by Downstream Industry in Russia 2013-2017 Table Demand Volume Forecast of Biotechnology in Europe by Downstream Industry 2018-2023 Table Sales Volume of Biotechnology in Europe by Major Players 2013-2017 Table Revenue of Biotechnology in Europe by Major Players 2013-2017 Table Headquarters Location and Established Time of Biotechnology Major Players Table Employees and Revenue Level of Biotechnology Major Players Table Representative Biotechnology Product One of Johnson & Johnson Services, Inc. Table Representative Biotechnology Product Two of Johnson & Johnson Services, Inc. Table Biotechnology Sales, Revenue, Price and Gross Margin of Johnson & Johnson Services, Inc. 2013-2017 Table Representative Biotechnology Product One of F. Hoffmann-La Roche Ltd Table Representative Biotechnology Product Two of F. Hoffmann-La Roche Ltd Table Biotechnology Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche Ltd 2013-2017 Table Representative Biotechnology Product One of Pfizer Table Representative Biotechnology Product Two of Pfizer Table Biotechnology Sales, Revenue, Price and Gross Margin of Pfizer 2013-2017 Table Representative Biotechnology Product One of Merck & Co. Table Representative Biotechnology Product Two of Merck & Co. Table Biotechnology Sales, Revenue, Price and Gross Margin of Merck & Co. 2013-2017 Table Representative Biotechnology Product One of Sanofi Table Representative Biotechnology Product Two of Sanofi Table Biotechnology Sales, Revenue, Price and Gross Margin of Sanofi 2013-2017 Table Representative Biotechnology Product One of AstraZeneca Table Representative Biotechnology Product Two of AstraZeneca Table Biotechnology Sales, Revenue, Price and Gross Margin of AstraZeneca 2013-2017 Table Representative Biotechnology Product One of Gilead Table Representative Biotechnology Product Two of Gilead Table Biotechnology Sales, Revenue, Price and Gross Margin of Gilead 2013-2017 Table Representative Biotechnology Product One of CELGENE CORPORATION Table Representative Biotechnology Product Two of CELGENE CORPORATION Table Biotechnology Sales, Revenue, Price and Gross Margin of CELGENE CORPORATION 2013-2017 Table Representative Biotechnology Product One of Biogen Table Representative Biotechnology Product Two of Biogen Table Biotechnology Sales, Revenue, Price and Gross Margin of Biogen 2013-2017 Table Representative Biotechnology Product One of Amgen, Inc Table Representative Biotechnology Product Two of Amgen, Inc Table Biotechnology Sales, Revenue, Price and Gross Margin of Amgen, Inc 2013-2017 Table Representative Biotechnology Product One of Abbott Table Representative Biotechnology Product Two of Abbott Table Biotechnology Sales, Revenue, Price and Gross Margin of Abbott 2013-2017 Table Representative Biotechnology Product One of Novo Nordisk A/S Table Representative Biotechnology Product Two of Novo Nordisk A/S Table Biotechnology Sales, Revenue, Price and Gross Margin of Novo Nordisk A/S 2013-2017 Table Representative Biotechnology Product One of Novartis AG Table Representative Biotechnology Product Two of Novartis AG Table Biotechnology Sales, Revenue, Price and Gross Margin of Novartis AG 2013-2017 Table Representative Biotechnology Product One of Lonza Table Representative Biotechnology Product Two of Lonza Table Biotechnology Sales, Revenue, Price and Gross Margin of Lonza 2013-2017